Lamb LA - Search Results

1

Brain and leptomeningeal metastases from cutaneous melanoma: survival outcomes based on clinical features.

Raizer JJ, Hwu WJ, Panageas KS, Wilton A, Baldwin DE, Bailey E, von Althann C, Lamb LA, Alvarado G, Bilsky MH, Gutin PH. Raizer JJ, et al. Among authors: lamb la. Neuro Oncol. 2008 Apr;10(2):199-207. doi: 10.1215/15228517-2007-058. Epub 2008 Feb 20. Neuro Oncol. 2008. PMID: 18287337 Free PMC article.

2

Diagnosis and management of stage I/II melanoma.

Lamb LA, Halpern AC, Hwu WJ. Lamb LA, et al. Semin Oncol Nurs. 2003 Feb;19(1):22-31. doi: 10.1053/sonu.2003.50001. Semin Oncol Nurs. 2003. PMID: 12638378 Review.

3

Phase II study of temozolomide plus thalidomide for the treatment of metastatic melanoma.

Hwu WJ, Krown SE, Menell JH, Panageas KS, Merrell J, Lamb LA, Williams LJ, Quinn CJ, Foster T, Chapman PB, Livingston PO, Wolchok JD, Houghton AN. Hwu WJ, et al. Among authors: lamb la. J Clin Oncol. 2003 Sep 1;21(17):3351-6. doi: 10.1200/JCO.2003.02.061. J Clin Oncol. 2003. PMID: 12947072 Clinical Trial.

4

Temozolomide plus thalidomide in patients with brain metastases from melanoma: a phase II study.

Hwu WJ, Lis E, Menell JH, Panageas KS, Lamb LA, Merrell J, Williams LJ, Krown SE, Chapman PB, Livingston PO, Wolchok JD, Houghton AN. Hwu WJ, et al. Among authors: lamb la. Cancer. 2005 Jun 15;103(12):2590-7. doi: 10.1002/cncr.21081. Cancer. 2005. PMID: 15861414 Free article. Clinical Trial.

5

Phase II study of temozolomide plus pegylated interferon-alpha-2b for metastatic melanoma.

Hwu WJ, Panageas KS, Menell JH, Lamb LA, Aird S, Krown SE, Williams LJ, Chapman PB, Livingston PO, Wolchok JD, Houghton AN. Hwu WJ, et al. Among authors: lamb la. Cancer. 2006 Jun 1;106(11):2445-51. doi: 10.1002/cncr.21909. Cancer. 2006. PMID: 16639739 Free article. Clinical Trial.

6

Follow-up recommendations for patients with American Joint Committee on Cancer Stages I-III malignant melanoma.

Poo-Hwu WJ, Ariyan S, Lamb L, Papac R, Zelterman D, Hu GL, Brown J, Fischer D, Bolognia J, Buzaid AC. Poo-Hwu WJ, et al. Cancer. 1999 Dec 1;86(11):2252-8. Cancer. 1999. PMID: 10590365

7

Chemotherapy of recurrent/advanced cervical cancer: results of the Yale University PBM-PFU protocol.

Chambers SK, Lamb L, Kohorn EI, Schwartz PE, Chambers JT. Chambers SK, et al. Gynecol Oncol. 1994 May;53(2):161-9. doi: 10.1006/gyno.1994.1110. Gynecol Oncol. 1994. PMID: 7514557 Free article.

8

A phase II trial of mitomycin C, 5-fluorouracil and radiation therapy in the treatment of unresectable non-small cell lung cancer.

Murren JR, Ganpule S, Papac R, Son YH, Peschel RE, Durivage H, Buzaid AC, Lamb L, Makuch R, Hait WN. Murren JR, et al. Oncol Res. 1993;5(2):53-7. Oncol Res. 1993. PMID: 8395915 Clinical Trial.

9

First-in-human phase II trial of the botanical formulation PHY906 with capecitabine as second-line therapy in patients with advanced pancreatic cancer.

Saif MW, Li J, Lamb L, Kaley K, Elligers K, Jiang Z, Bussom S, Liu SH, Cheng YC. Saif MW, et al. Cancer Chemother Pharmacol. 2014 Feb;73(2):373-80. doi: 10.1007/s00280-013-2359-7. Epub 2013 Dec 3. Cancer Chemother Pharmacol. 2014. PMID: 24297682 Free PMC article. Clinical Trial.

10

A phase I study of the antimetabolite (E)-2'-fluoromethylene-2'-deoxycytidine (MDL 101,731) administered as a twice-weekly infusion.

Burtness B, Belker M, Stoltz M, Peccerillo KM, Lamb LA, Chmael SE, McKeon A, Clark MB, Winship J, Marsh JC, Pizzorno G, DeVita VT Jr. Burtness B, et al. Among authors: lamb la. Cancer J. 2000 Sep-Oct;6(5):309-15. Cancer J. 2000. PMID: 11079170 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

18 results

Search Page

Filters